Skip to content
Trial Eligibility
Menu

Schizophrenia Clinical Trials near Chicago, IL

26 studies for Schizophrenia are recruiting at 29 sites within 50 miles of Chicago, Illinois, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Schizophrenia trials in the US or all trials near Chicago.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Schizophrenia studies enrolling near Chicago

Showing 26 studies, nearest first.
  1. NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

    NCT07114874

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: Neurocrine Clinical Site (Chicago, IL); Neurocrine Clinical Site (Oak Brook, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  2. A Study to Evaluate the Effect of KarXT on Urological Safety

    NCT07221877

    • Phase 4
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: Pillar Clinical Research -Chicago (Chicago, IL); Uptown Research Institute (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

    NCT07467993

    • Phase 2
    • Ages 18 to 65 years
    • Sex: All

    Nearest sites: Pillar Clinical Research LLC (Chicago, IL); Uptown Research Institute LLC (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. CLOZAPINE Response in Biotype-1

    NCT04580134

    • Phase 4
    • Ages 18 to 60 years
    • Sex: All

    Nearest site: University of Chicago (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  5. Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

    NCT05184335

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Reviva site (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

    NCT05303064

    • Phase 3
    • Ages 10 to 17 years
    • Sex: All

    Nearest site: Alkermes Investigator Site (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. Study of ALTO-101 in Patients With Schizophrenia

    NCT06502964

    • Phase 2
    • Ages 21 to 55 years
    • Sex: All

    Nearest site: Site 5056 (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

    NCT06740383

    • Observational
    • Ages 18 to 40 years
    • Sex: All

    Nearest site: University of Chicago Medical Center (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Randomized Withdrawal Study in Patients With Schizophrenia

    NCT06961968

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Vanda Investigational Site (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

    NCT06963034

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Neurocrine Clinical Site (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

    NCT07061288

    • Phase 1
    • Ages 18 to 55 years
    • Sex: All

    Nearest site: Uptown Research Institute (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

    NCT07191483

    • Phase 2
    • Ages 18 to 55 years
    • Sex: All

    Nearest site: Uptown Research Institute (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

    NCT07288567

    • Phase 3
    • Ages 13 to 17 years
    • Sex: All

    Nearest site: EmVenio Research Center - Prime Healthcare (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

    NCT07363577

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Pillar Clinical Research (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. 52-week Open Label Safety-Tolerability Study

    NCT07369154

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Pillar Clinical Research (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Study of Brenipatide in Adult Participants With Schizophrenia

    NCT07410507

    • Phase 2
    • Ages 18 to 55 years
    • Sex: All

    Nearest site: Re:Cognition Health - Chicago (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

    NCT07424404

    • Phase 3
    • Ages 5 to 17 years
    • Sex: All

    Nearest site: EmVenio Research Center - Prime Healthcare (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

    NCT07459647

    • Phase 2
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Clinical Site (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

    NCT07615426

    • Phase 1
    • Ages 18 to 55 years
    • Sex: All

    Nearest site: Uptown Research Institute (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

    NCT07686263

    • Phase 3
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Pillar Clinical Research -Chicago (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

    NCT07853807

    • Interventional
    • Ages 18 to 59 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: The University of Chicago (Chicago, IL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

    NCT07101094

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Evanston Hospital (Evanston, IL)

    Distance to nearest recruiting site
    ~13 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Transition Care for FEP

    NCT07713849

    • Observational
    • Ages 18 to 40 years
    • Sex: All

    Nearest site: University of Chicago Ingalls Memorial Hospital (Harvey, IL)

    Distance to nearest recruiting site
    ~17 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

    NCT06229210

    • Phase 3
    • Ages 5 to 17 years
    • Sex: All

    Nearest site: Baber Research Group (Naperville, IL)

    Distance to nearest recruiting site
    ~26 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

    NCT07105111

    • Phase 4
    • Ages 18 years and older
    • Sex: All

    Nearest site: Neurocrine Clinical Site (Naperville, IL)

    Distance to nearest recruiting site
    ~26 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

    NCT07379827

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Amr Conventions Research - Illinois (Warrenville, IL)

    Distance to nearest recruiting site
    ~27 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Schizophrenia clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.